The role of cardiovascular biomarkers in clinical trials-Reference-Cited by-同舟云学术

The role of cardiovascular biomarkers in clinical trials

Published:2018-08-01 Issue:suppl_G Volume:20 Page:G45-G47
ISSN:1520-765X
Container-title:European Heart Journal Supplements
language:en
Short-container-title:

Author:

Arrigo Mattia¹,Gayat Etienne²³⁴

Affiliation:

1. Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland

2. Department of Anaesthesiology and Intensive Care, Lariboisière Hospital, Paris, France

3. Inserm UMR-S 942, Hôpital Lariboisière, Paris, France

4. Université Paris Diderot-Sorbonne Paris Cité, Paris, France

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartjsupp/article-pdf/20/suppl_G/G45/25205338/suy022.pdf

Reference6 articles.

1. Surfing the biomarker tsunami at JACC: heart failure;Januzzi;JACC Heart Fail,2013

2. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Greenland;Circulation,2010

3. Redefining the role of biomarkers in heart failure trials: expert consensus document;Kramer;Heart Fail Rev,2017

4. Two decades of cardiovascular trials with primary surrogate endpoints: 1990-2011;Bikdeli;J Am Heart Assoc,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gaining Efficiency in Clinical Trials With Cardiac Biomarkers;Journal of the American College of Cardiology;2021-04

2. Cardiac imaging and circulating biomarkers for primary prevention in the era of precision medicine;Expert Review of Precision Medicine and Drug Development;2019-09-03